A Plus Biotechnology Co., Ltd. (TPE:6918)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
74.30
-0.50 (-0.67%)
At close: Apr 29, 2026
-30.88%
Market Cap 2.50B
Revenue (ttm) 835.89M
Net Income (ttm) 169.38M
Shares Out 33.70M
EPS (ttm) 5.15
PE Ratio 14.43
Forward PE n/a
Dividend 5.00 (6.68%)
Ex-Dividend Date Mar 27, 2026
Volume 29,328
Average Volume 71,578
Open 74.90
Previous Close 74.80
Day's Range 73.80 - 74.90
52-Week Range 72.70 - 136.00
Beta 0.20
RSI 40.32
Earnings Date May 11, 2026

About A Plus Biotechnology

A Plus Biotechnology Co., Ltd. engages in the manufacturing and wholesale of orthopedic and other medical devices. The company offers products for chest, shoulder, spine, elbow, wrist and hand, pelvic and hip, knee, foot and ankle, osteotomy, pediatric and ESF, biologics. It also provides bone grafts. A Plus Biotechnology Co., Ltd. was founded in 2009 and is based in New Taipei City, Taiwan. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2009
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 6918
Full Company Profile

Financial Performance

In 2025, A Plus Biotechnology's revenue was 835.89 million, an increase of 8.61% compared to the previous year's 769.59 million. Earnings were 169.38 million, an increase of 12.13%.

Financial Statements

News

There is no news available yet.